Loading...
Neprilysin inhibition: a new therapeutic option for type 2 diabetes?
Neprilysin is a widely expressed peptidase with broad substrate specificity that preferentially hydrolyses oligopeptide substrates, many of which regulate the cardiovascular, nervous and immune systems. Emerging evidence suggests that neprilysin also hydrolyses peptides that play an important role i...
Na minha lista:
| Udgivet i: | Diabetologia |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6579747/ https://ncbi.nlm.nih.gov/pubmed/31089754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-019-4889-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|